An open-label, clinical pharmacology study to investigate drug-drug interaction in patients with RA [rheumatoid arthritis]
Phase of Trial: Phase I/II
Latest Information Update: 14 Dec 2008
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 14 Dec 2008 Actual end date (August 2005) added as reported by CT.gov
- 13 Aug 2007 Status changed from in progress to completed.
- 04 Dec 2005 New trial record.